AVBP - Latest News
ArriVent BioPharma, Inc. Common Stock (AVBP), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $1.35B. Beta to the broader market is 1.52.
The article list below shows the most recent AVBP headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent AVBP Headlines
ArriVent BioPharma: Stronger Balance Sheet And Pipeline Upside Reinforce Our Bull Case
seekingalpha.com - May 16, 2026
Management reiterated that the move from early 2026 to mid-2026 was driven by slower event accumulation rather than operational issues, enrollment cha
ArriVent BioPharma Reports First Quarter 2026 Financial Results
globenewswire.com - May 11, 2026
NEWTOWN SQUARE, Pa. , May 11, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc.
ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers
globenewswire.com - May 7, 2026
NEWTOWN SQUARE, Pa. , May 07, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc.
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Average Recommendation of “Moderate Buy” by Analysts
defenseworld.net - Apr 24, 2026
Shares of ArriVent BioPharma, Inc. (NASDAQ: AVBP - Get Free Report) have earned an average recommendation of "Moderate Buy" from the twelve ratings f
Are You Looking for a Top Momentum Pick? Why ArriVent BioPharma, Inc. (AVBP) is a Great Choice
zacks.com - Apr 15, 2026
Does ArriVent BioPharma, Inc. (AVBP) have what it takes to be a top stock pick for momentum investors?
How News Affects AVBP Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track AVBP's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked AVBP news questions
- What is the latest AVBP news headline?
- The most recent AVBP headline (May 16, 2026) is "ArriVent BioPharma: Stronger Balance Sheet And Pipeline Upside Reinforce Our Bull Case". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the AVBP news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What AVBP news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual AVBP options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.